Despite significant advances in healthcare, low neonatal mortality and child mortality rates are still a distant dream for India. In the country, less than 2% of newborn the babies are screened annually for 1-4 disorders. With the government focus on achieving the 2030 Sustainable Development Goals on child and neonatal mortality, the support of corporates assumes a vital role. The goals which were agreed upon under the United Nations Development Programme, involve the reduction of child mortality to 25 per 1,000 live births and neonatal mortality to 12 per 1,000 live births.
“Unfortunately, after more than a decade of pilot testing in India – the overwhelming majority of births are not screened. Based on the experience of global newborn screening programs, there are four key factors that have been identified as essential for a successful and sustainable program: 1. Government prioritisation, 2. Public awareness and education, 3. Health practitioner involvement and 4. Government support in mandating and funding an NBS programme within the existing healthcare system” said Mr. Prahlad Singh, Senior Vice President, PerkinElmer.
“Worldwide, approximately 136 million babies are born per year, of which 49 million babies are screened annually. We estimate 40-45 million are screened annually of 140 million babies born. Of the 87 million babies not screened, 27 million are born in India. The single largest volume newborn screening lab globally is located in Cairo, Egypt, where more than 1.2 Million samples are screened annually for congenital hypothyroidism. China has approximately 17 Million births annually, with more than 85% being screened in laboratories across the country. Newborns in Australia, Korea, the Philippines, Vietnam and other neighboring countries are also screened for 3 – 5 disorders.” he said.
Perkin Elmer is committed to lending support to government’s healthcare initiatives and helping the country achieve a single digit neonatal rate by 2030.
“We are committed to contributing to national health policies in India and state government initiatives, bringing technology advancement, innovation, and quality in healthcare service delivery. We continue to collaborate and welcome partnerships with various government agencies, such as the Indian Council of Medical Research, Biotechnology Industry Research Assistance Council, Indian Institute for Technology and professional associations, namely Indian Academy of Paediatrics, FOGSI, National Neonatology Forum, Indian Medical Association, Indian Association for Medical Genetics to help meet young entrepreneurial researchers’ needs as they work toward advancing their science and developing transformational solutions,” Dr. Singh said.
“In India, we are looking to support both the national and state governments’ efforts to achieve various targets to achieve sustainable development goals, such as to end preventable newborn deaths to achieve a single digit neonatal mortality rate by 2030; and to achieve universal and equitable access to safe and affordable drinking water for all by 2030,” Dr Ruchi Sogarwal, PerkinElmer, added.
Thank you for reading the story until the very end. We appreciate the time you have given us. In addition, your thoughts and inputs will genuinely make a difference to us. Please do drop in a line and help us do better.
The CSR Journal Team